FDC
Aditya Nandgaonkar is a quality assurance professional with extensive experience in the pharmaceutical industry. Currently serving as a Quality Assurance Executive at FDC Limited since March 2020, Aditya also holds the position of Senior Executive at Cipla since September 2017. Previous roles include QA Officer at Merck Ltd. from February 2016 to September 2017 and Jr. QA Officer at Ciron Drugs And Pharmaceuticals Private Limited from December 2014 to January 2016. Aditya’s educational background includes a Master of Pharmacy in Quality Assurance and Techniques from Savitribai Phule Pune University and a Bachelor's Degree in Pharmaceutical Sciences from Sudhakarrao Naik Institute Of Pharmacy, complemented by an Associate's Degree in Pharmacy.
This person is not in any offices
FDC
FDC Limited is a pharmaceutical company. The Company is engaged in manufacture of specialized formulations, and oral rehydration salts (ORS). Its therapeutic areas of focus include anti-infectives, gastrointestinals, ophthalmologicals, vitamins/minerals/dietary supplements, cardiac, anti-diabetes, respiratory, gynecology, dermatology and analgesics. It has a range of functional foods and beverages. Its active pharmaceuticals ingredients (APIs) produced cover a range of therapeutic categories, such as Albuterol Sulfate, Bromhexine Hydrochloride, Cinnarizine, Flunarizine Dihydrochloride, Flurbiprofen, Flurbiprofen Sodium, Miconazole Nitrate and Timolol Maleate. Its brands include Zifi, Electral, Enerzal, Vitcofol, Pyrimon, Zocon, Zoxan, Zathrin, Zipod, Zefu, Cotaryl and Mycoderm. It has multi-location manufacturing facilities for APIs, as well as finished dosage forms. Its facilities are located at Roha, Waluj and Sinnar in Maharashtra, Verna in Goa and Baddi in Himachal Pradesh.